Magnified Intelligence Chromoendoscopy Plus Probe-based Confocal Laser Endomicroscopy for Gastric Intestinal Metaplasia Diagnosis
1 other identifier
interventional
45
1 country
1
Brief Summary
Magnified intelligence chromoendoscopy (FICE) plus probe-based confocal laser endomicroscopy (pCLE) for Gastric Intestinal Metaplasia (GIM) diagnosis: a feasibility trial Research Question: Is confocal endomicroscope feasible to diagnose gastric intestinal metaplasia? Objective: To evaluate the feasibility of confocal endomicroscope in diagnose gastric intestinal metaplasia. Hypothesis: Confocal endomicreosocpe can provide the accurate diagnosis of gastric intestinal metaplasia. Research design: Diagnostic study Sample size: The investigators follow the population in recent study from Imraporn et al.: Validity of magnify NBI for gastric intestinal metaplasia targeted biopsy (N= 50) Data analysis: Confocal Barrett's esophagus classification was used to evaluate agreement of confocal endomicroscopic finding in gastric intestinal metaplasia. The accuracy of new criteria for GIM by confocal endomicroscope was evaluated in relation to pathological report, a gold standard for diagnosis, and reported as sensitivity, specificity, positive predictive value, negative predictive value and accuracy of these criteria. Expected Benefit and Application: The feasibility of confocal endomicroscopy for diagnosis gastric intestinal metaplasia in order to improve the quality of GIM/dysplasia/early gastric cancer detection and then decrease the mortality rate from gastric cancer in the future.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedFirst Submitted
Initial submission to the registry
December 5, 2011
CompletedFirst Posted
Study publicly available on registry
December 9, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2012
CompletedJune 11, 2014
June 1, 2014
1.7 years
December 5, 2011
June 9, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The feasibility of confocal endomicroscope in diagnose gastric intestinal metaplasia
If GIM can be detected properly, early gastric cancer(EGC) will be in early recognition. EGC can be cured by endoscopic resection and then the mortality rate from gastric cancer will be decrease.
Up to 2 years
Study Arms (2)
Gastric intestinal metaplasia
EXPERIMENTALNormal
PLACEBO COMPARATORInterventions
Confocal laser endomicroscopy was applied at suspected lesion and normal mucosa followed by biopsy for pathology.
Eligibility Criteria
You may qualify if:
- Age 18-80 year-old
- All patients were diagnosed GIM in the past 2 years.
- All patients have to sign the consent form
You may not qualify if:
- Previous gastric surgery including gastrectomy and bypass surgery
- Bleeding tendency including decompensated cirrhosis, chronic kidney disease and long-tem antiplatelets or anticoagulants
- Pregnanacy
- History of fluorescein allergy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rapat Pittayanon
Bangkok, Bangkok, 10330, Thailand
Related Publications (1)
Pittayanon R, Rerknimitr R, Wisedopas N, Ridtitid W, Kongkam P, Treeprasertsuk S, Angsuwatcharakon P, Mahachai V, Kullavanijaya P. Flexible spectral imaging color enhancement plus probe-based confocal laser endomicroscopy for gastric intestinal metaplasia detection. J Gastroenterol Hepatol. 2013 Jun;28(6):1004-9. doi: 10.1111/jgh.12185.
PMID: 23432088DERIVED
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principle investigator
Study Record Dates
First Submitted
December 5, 2011
First Posted
December 9, 2011
Study Start
April 1, 2010
Primary Completion
December 1, 2011
Study Completion
February 1, 2012
Last Updated
June 11, 2014
Record last verified: 2014-06